Loading...
Stryker's Q3 2023 results showed a 9.6% increase in reported net sales, reaching $4.9 billion. Organic net sales grew by 9.2%. The adjusted EPS increased by 16.0% to $2.46.
Reported net sales increased 9.6% to $4.9 billion.
Organic net sales increased 9.2%.
Adjusted EPS increased 16.0% to $2.46.
Company expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5%.
Stryker expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5% including slightly positive pricing for the year. Adjusted net earnings per diluted share are expected to be in the range of $10.35 to $10.45.